Ribavirin does not impact health-related quality of life (HRQOL) in patients on Ombitasvir/ Paritaprevir /Ritonavir and dasabuvir at the end of 12-week treatment in Treatment-NaÏve adults with Genotype 1A (GT1A) Chronic Hepatitis C
May 1, 2015, 00:00
10.1016/j.jval.2015.03.1316
https://www.valueinhealthjournal.com/article/S1098-3015(15)01373-X/fulltext
Title :
Ribavirin does not impact health-related quality of life (HRQOL) in patients on Ombitasvir/ Paritaprevir /Ritonavir and dasabuvir at the end of 12-week treatment in Treatment-NaÏve adults with Genotype 1A (GT1A) Chronic Hepatitis C
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01373-X&doi=10.1016/j.jval.2015.03.1316
First page :
A227
Section Title :
Gastrointestinal Disorders
Open access? :
No
Section Order :
783